Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses

Objective In SUSTAIN 7, once-weekly semaglutide demonstrated superior glycated haemoglobin (HbA1c) and body weight (BW) reductions versus once-weekly dulaglutide in subjects with type 2 diabetes (T2D). This post hoc analysis investigated the impact of clinically relevant subject characteristics on t...

Full description

Saved in:
Bibliographic Details
Main Authors: Ildiko Lingvay, Emre Yildirim, Richard E Pratley, Vanita R Aroda, Andrei-Mircea Catarig, Jörg Lüdemann, Adie Viljoen
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/11/e037883.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items